A 2-Week, Polysomnographic, Safety Study of Sodium Oxybate in Obstructive Sleep Apnea Syndrome
Sleep & breathing(2010)
摘要
Sodium oxybate (SXB) is approved for cataplexy and excessive daytime sleepiness in narcolepsy. Obstructive sleep apnea syndrome (OSAS) affects ∼9–50% of narcoleptics. Effects of 2-week SXB administration on apnea–hypopnea index (AHI), oxygen saturation (SaO2), and sleep architecture were investigated in OSAS patients.
更多查看译文
关键词
Xyrem/sodium oxybate,Gamma-hydroxybutyrate/GHB,Sleep apnea,Polysomnography,Slow wave sleep,Oxygen saturation
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要